来自MSN11 个月
AstraZeneca Pharma rises 4% on getting CDSCO nod to import cancer treatment drug
Trastuzumab deruxtecan lyophilized powder concentrate for solution for infusion 100mg (Enhertu) from the Central Drugs Standard Control Organisation. Trastuzumab deruxtecan is indicated for the ...